The rivalry between Pfizer and MSD in pneumococcal vaccines has dialled up a notch with the FDA approval of MSD’s new shot Capvaxive, the first to be aimed specifically at adults. The 21-valent ...

I say I'm a points and carburetor kind of guy because in my mind I figure if they go wrong I can fix 'em at the side of the road. However, they both require fiddling with to get an engine to run right ...

A subcutaneous formulation of MSD's top-selling cancer immunotherapy, Keytruda, was non-inferior to the current intravenous version in a head-to-head trial, setting up regulatory filings. The new ...

On December 28, The National Safety Council released the 2023-2024 MSD Solutions Index Pledge Community Report, which revealed progress in addressing one of the most pervasive workplace injuries: ...

In 2021, to address the continuing musculoskeletal disorders, or MSDs, which are the most common workplace injury, the National Safety Council created the MSD Solutions Lab. The cost of these injuries ...